Literature DB >> 18375831

Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn- alpha-chain deficient mice.

Jonghan Kim1, C L Bronson, Manzoor A Wani, Tatiana M Oberyszyn, Sudhasri Mohanty, Chaity Chaudhury, William L Hayton, John M Robinson, Clark L Anderson.   

Abstract

FcRn, a nonclassical MHC-I protein bound to beta 2-microglobulin (beta 2m), diverts IgG and albumin from an intracellular degradative fate, prolonging the half-lives of both. While knockout mouse strains lacking either FcRn-alpha-chain (AK) or beta 2m (BK) show much shorter half-lives of IgG and albumin than normal mice, the plasma IgG half-life in the BK and AK strains is different, being shorter in the BK strain. Since beta 2m does not affect the IgG production rate, we tested whether an additional beta 2m-associated mechanism protects IgG from catabolism. First, we compared the fractional disappearance rate in plasma of an intravenous dose of radioiodinated IgG in a mouse strain deficient in both FcRn-alpha-chain and beta 2m (ABK), in the two parental knockout strains (AK and BK), and in the background wild-type (WT) strain. We found that IgG survived longer in the beta 2m-expressing AK strain than in the beta 2m-lacking ABK and BK strains, whereas the IgG half-lives between the ABK and BK strains were identical. Then we compared endogenous concentrations of four typical plasma proteins among the four strains and found that steady-state plasma concentrations of both IgG and albumin were higher in the AK strain than in either the BK or the ABK strain. These results suggest that a beta 2m-associated effect other than FcRn prolongs the survival of both IgG and albumin, although leaky gene transcription in the AK strain cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375831     DOI: 10.3181/0710-RM-270

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  13 in total

Review 1.  Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn.

Authors:  Kristi Baker; Shuo-Wang Qiao; Timothy Kuo; Kanna Kobayashi; Masaru Yoshida; Wayne I Lencer; Richard S Blumberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

2.  Divergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigens.

Authors:  Charles W Armitage; Connor P O'Meara; Marina C G Harvie; Peter Timms; Richard S Blumberg; Kenneth W Beagley
Journal:  Immunol Cell Biol       Date:  2014-01-21       Impact factor: 5.126

Review 3.  Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics.

Authors:  Timo Rath; Kristi Baker; Jennifer A Dumont; Robert T Peters; Haiyan Jiang; Shuo-Wang Qiao; Wayne I Lencer; Glenn F Pierce; Richard S Blumberg
Journal:  Crit Rev Biotechnol       Date:  2013-10-24       Impact factor: 8.429

Review 4.  The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy.

Authors:  Jonathan T Sockolosky; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2015-02-19       Impact factor: 15.470

5.  Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.

Authors:  Marie-Alice Vitry; Carl De Trez; Stanislas Goriely; Laure Dumoutier; Shizuo Akira; Bernhard Ryffel; Yves Carlier; Jean-Jacques Letesson; Eric Muraille
Journal:  Infect Immun       Date:  2012-09-24       Impact factor: 3.441

6.  Neutralizing activity and protective immunity to ricin toxin conferred by B subunit (RTB)-specific Fab fragments.

Authors:  Anastasiya Yermakova; Nicholas J Mantis
Journal:  Toxicon       Date:  2013-04-17       Impact factor: 3.033

Review 7.  Colostrogenesis: IgG1 transcytosis mechanisms.

Authors:  Craig R Baumrucker; Rupert M Bruckmaier
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-01-29       Impact factor: 2.673

8.  Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats.

Authors:  Elizabeth M Laurenzana; Howard P Hendrickson; Dylan Carpenter; Eric C Peterson; W Brooks Gentry; Michael West; Yingni Che; F Ivy Carroll; S Michael Owens
Journal:  Vaccine       Date:  2009-10-01       Impact factor: 3.641

Review 9.  The Implication and Significance of Beta 2 Microglobulin: A Conservative Multifunctional Regulator.

Authors:  Ling Li; Mei Dong; Xiao-Guang Wang
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628

Review 10.  Immunoglobulin Transporting Receptors Are Potential Targets for the Immunity Enhancement and Generation of Mammary Gland Bioreactor.

Authors:  Xuemei Jiang; Jianjun Hu; Diraviyam Thirumalai; Xiaoying Zhang
Journal:  Front Immunol       Date:  2016-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.